Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-26-023263
Filing Date
2026-03-03
Accepted
2026-03-03 18:24:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 20800
2 JOINT FILING AGREEMENT ea027953601ex99-1.htm EX-99.1 23358
  Complete submission text file 0001213900-26-023263.txt   45854
Mailing Address 125 SUMMER STREET BOSTON MA 02110
Business Address 125 SUMMER STREET BOSTON MA 02110 7818487100
HAEMONETICS CORP (Subject) CIK: 0000313143 (see all company filings)

EIN.: 042882273 | State of Incorp.: MA | Fiscal Year End: 0328
Type: SCHEDULE 13G | Act: 34 | File No.: 005-48277 | Film No.: 26717460
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 405 LEXINGTON AVENUE SUITE 5001 NEW YORK NY 10174
Business Address 405 LEXINGTON AVENUE SUITE 5001 NEW YORK NY 10174 212-209-3904
North Peak Capital Management, LLC (Filed by) CIK: 0001747888 (see all company filings)

EIN.: 474443582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G